Neogen Corporation (NEOG) News
Follow Neogen Corporation (NEOG) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 23 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Neogen Shifts Focus to Scale Profitable Growth
Neogen Corp. (NASDAQ: NEOG ) stock fell on Wednesday even after the company reported better-than-expected first-quarter financial results. First-Quarter Financial Performance Overview First-quarter 2027 adjusted earnings
LIVE | Oct 07, 2026, 03:02 PM UTC
M
Neogen shares jump after Q3 results and raised guidance
Neogen shares rose 14.1% in pre-market after reporting third-quarter 2026 results and raising its full-year revenue and adjusted EBITDA guidance.
EQUITY | Oct 07, 2026, 02:02 PM UTC
H
Why Penguin Solutions Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Shares of Penguin Solutions, Inc. (NYSE: PENG ) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY27 EPS guidance above estimates. The compan
LIVE | Oct 07, 2026, 08:38 AM UTC
H
Full Transcript: Neogen Q1 2027 Earnings Call
Neogen (NASDAQ: NEOG ) held its first-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit Vie
LIVE | Oct 06, 2026, 09:09 PM UTC
M
Neogen Corporation Reports Q1 Earnings Summary
Neogen Corporation reported its earnings summary for the quarter ended August 31. The figures are in US dollars unless otherwise stated.
EQUITY | Oct 06, 2026, 09:00 PM UTC
H
Neogen shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY27 sales guidance.
Neogen shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY27 sales guidance.
LIVE | Oct 06, 2026, 08:16 PM UTC
M
Neogen Reports 1Q Revenue of $222.8M
Neogen reported first-quarter revenue of $222.8 million.
EARNINGS | Oct 06, 2026, 08:14 PM UTC
H
Neogen Raises FY2027 Sales Guidance from $880.000M-$885.000M to $885.000M-$890.000M vs $883.175M Est
Neogen (NASDAQ: NEOG ) raises FY2027 sales outlook from $880.000 million-$885.000 million to $885.000 million-$890.000 million vs $883.175 million estimate.
LIVE | Oct 06, 2026, 08:02 PM UTC
M
Neogen Reports Q1 FY27 Financial Results
Neogen Corporation announced its financial results for the first quarter of fiscal year 2027, noting a shift in focus towards strengthening and scaling fundamentals for consistent execution and improved performance.
EQUITY | Oct 06, 2026, 08:01 PM UTC
M
Neogen Reports 1Q Loss of $11.9 Million
Neogen (NEOG) announced a first-quarter loss of $11.9 million.
EARNINGS | Oct 06, 2026, 08:01 PM UTC
H
Stock Market: Will S&P 500 Open Up or Down Today?
U.S. stock futures are trending slightly higher early Tuesday as Wall Street navigates a quiet global trading session, digesting a severe economic crisis unfolding in Iran, elevated Treasury yields, and the onset of the
LIVE | Oct 06, 2026, 06:12 AM UTC
L
Neogen Price Target Raised to $14.00/Share From $12.00 by Guggenheim
Ratings actions from Benzinga
NEWS | Sep 30, 2026, 12:38 PM UTC
L
Guggenheim maintains Buy rating on Neogen, $14 price target
Guggenheim maintained their Buy rating on Neogen's stock with a price target of $14.00.The price target implies an upside of 10.0% from the Sep 29 close of $12.73.Key takeaways from the analyst noteOperational Improvemen
EQUITY | Sep 30, 2026, 12:28 PM UTC
L
Neogen (NEOG) Stock Trades Down, Here Is Why
What Happened? Shares of life sciences company Neogen NASDAQ:NEOGfell 5.4% in the afternoon session after the U.S. Food and Drug Administration issued warning letters to the company following laboratory tests that uncove
REGULATION | Sep 29, 2026, 07:57 PM UTC
L
FDA Issues Warning Letters To Neogen, Sciarra Aeromed For Fungal Contamination In Sterile Veterinary Wound Product
FDA
REGULATION | Sep 29, 2026, 03:39 PM UTC
H
NEOG Q1'26 Earnings: revenue estimate is 208.18M USD
NEOG (Neogen Corporation) is set to announce its Q1'26 results on October 06, before the market opens. The earnings are expected to be disclosed at 7:00 AM ET (11:00 AM UTC).For Q1'26, revenue estimate is 208.18 million
EARNINGS | Sep 29, 2026, 11:00 AM UTC
H
NEOG - Neogen Announces First-Quarter Earnings Release Date
NEOG - Neogen Announces First-Quarter Earnings Release Date
EARNINGS | Sep 15, 2026, 08:38 PM UTC
M
Neogen sets Oct. 6, 2026 earnings release and webcast time
Neogen will issue first-quarter earnings after the market close Oct. 6, 2026, with a webcast and conference call starting 4:30 p.m. ET.
EQUITY | Sep 15, 2026, 08:30 PM UTC
L
Neogen to host investor day on October 7, 2026
Neogen plans an investor day on October 7, 2026.
EQUITY | Sep 08, 2026, 01:06 PM UTC
L
Neogen to host Investor Day on Oct. 7, 2026
Neogen Corp. will host an Investor Day on Wednesday, Oct. 7, 2026, at 9 a.m. ET in New York City, focused on its strategic transformation and commercial capabilities.
EQUITY | Sep 08, 2026, 01:00 PM UTC
L
Neogen price target raised by Piper Sandler
Piper Sandler raised its price target on Neogen from $13.00 to $14.00 per share, according to TradingView News.
EQUITY | Aug 26, 2026, 04:53 PM UTC
L
NEOG Neogen RESULTS: Q4, Q4 ADJ Net Income $18.7M vs. EST $-14M, Q4 EPS $-0.05, Q4 Net Income $-11.3M, Q4 ADJ EBITDA margin 20.2%, Q4 REV $2
NEOG Neogen RESULTS: Q4, Q4 ADJ Net Income $18.7M vs. EST $-14M, Q4 EPS $-0.05, Q4 Net Income $-11.3M, Q4 ADJ EBITDA margin 20.2%, Q4 REV $225.3M vs. EST $212.4M, Q4 ADJ EBITDA $45.4M vs. EST $42.2M, Q4 ADJ EPS $0.09 vs.
EARNINGS | Jul 30, 2026, 11:06 AM UTC
L
NEOG - Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results
NEOG - Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results
EQUITY | Jul 30, 2026, 11:02 AM UTC